Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-01-01 @ 2:25 PM
Study NCT ID:
NCT00357656
Status:
COMPLETED
Last Update Posted:
2021-05-19
First Post:
2006-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery
Sponsor:
Baxalta now part of Shire
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
060402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |